Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
01/22/2014 | CN103524436A 1-[(3-alkoxy-6-substituted-quinoxalin-2-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
01/22/2014 | CN103524435A Hapten and complete antigen of mequindox residual marker (dedioxo mequindox) and preparation method thereof |
01/22/2014 | CN103524434A Small molecular inhibitor pyrazinamide used in plant ethylene synthesis and application thereof |
01/22/2014 | CN103520160A Application of peptide compound in rhizoma sparganii |
01/22/2014 | CN102285850B Method for preparing amide from nitrile by hydration in presence of supported gold as catalyst |
01/22/2014 | CN102112451B Diazepan and piperazine derivatives modulators of chemokine receptors |
01/21/2014 | US8633307 Dark quenchers for donor-acceptor energy transfer |
01/21/2014 | US8633197 Piperidine/piperazine derivatives |
01/15/2014 | CN103508964A Star-shaped phenanthrooxaline derivatives, preparation method and application thereof as well as electroluminescent device |
01/15/2014 | CN103508963A Preparation method of acipimox |
01/15/2014 | CN102558076B 1-oxygen-2-hydroxylmethyl-3-(1-ethoxyl)-quinoxaline, as well as preparation method and application of 1-oxygen-2-hydroxylmethyl-3-(1-ethoxyl)-quinoxaline |
01/14/2014 | US8629156 Tryptophan hydroxylase inhibitors |
01/14/2014 | US8629149 Oxopiperazine derivatives for the treatment of pain and epilepsy |
01/09/2014 | WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors |
01/09/2014 | WO2014005968A1 Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
01/09/2014 | US20140011813 Medicine for Treating Ischemic Brain Injury and its Sequelae, and Preparation Method Thereof |
01/09/2014 | US20140011786 Synthesis and use of anti-tumor drug lqc-y |
01/09/2014 | CA2876443A1 Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
01/08/2014 | CN103502244A Compound for increasing kinase active and application thereof |
01/08/2014 | CN103497163A Synthesis method of dimethyl isobutyl pyrazine |
01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
01/08/2014 | CN102532043B 1-oxo-2-(1-hydroxyethyl)3-hydroxymethyl-quinoxaline and preparation method and application thereof |
01/08/2014 | CN102351802B Method for synthesizing N-monosubstituted piperazine-2,3-dione |
01/07/2014 | US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
01/07/2014 | US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |
01/07/2014 | CA2660424C Sulfonamide compound or salt thereof |
01/03/2014 | WO2014005129A1 Cyanoguanidines and their use as antiviral agents |
01/03/2014 | WO2014002105A1 Compounds for the treatment of dyslipidemia and other diseases |
01/03/2014 | WO2014001802A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
01/03/2014 | CA2877449A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
01/03/2014 | CA2877326A1 Cyanoguanidines and their use as antiviral agents |
01/02/2014 | US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders |
01/01/2014 | EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
01/01/2014 | EP2678317A1 Benzamide derivatives as p2x7 receptor antagonists |
12/31/2013 | US8618296 Arylethynyl derivatives |
12/31/2013 | US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
12/31/2013 | US8618108 Methods of making cyclic, N-amino functional triamines |
12/27/2013 | WO2013191112A1 Fused heterocyclic compound |
12/25/2013 | CN103467392A Polyhalogenated pyrazinecarboxamide derivative and salts, preparation method and application thereof |
12/25/2013 | CN103467391A Diaryl methyl piperazine compounds containing saturated nitrogen heterocyclic amide and application thereof |
12/25/2013 | CN101935306B Diketone piperazidine-like derivative and application thereof |
12/24/2013 | US8614229 Substituted indole derivatives and methods of use thereof |
12/24/2013 | DE112012000828T5 Lichtemittierendes Element The light-emitting element |
12/19/2013 | US20130338151 Fused ring analogues of anti-fibrotic agents |
12/19/2013 | US20130338095 Chemosensory Receptor Ligand-Based Therapies |
12/19/2013 | US20130336918 Compounds and methods for inhibiting phosphate transport |
12/18/2013 | EP2673265A2 Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine |
12/18/2013 | EP2445868B1 Biphenyl amides useful as p2x3 and/or p2x2/3 receptors modulators |
12/18/2013 | EP1616864B1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
12/18/2013 | CN103450885A Organic luminescent material based on quinoxaline diamine skeleton and preparation method thereof |
12/18/2013 | CN103450098A Method for synthesizing 2, 5-diphenyl pyrazine |
12/17/2013 | US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof |
12/12/2013 | WO2013181741A1 Imino compounds as protecting agents against ultraviolet radiations |
12/12/2013 | WO2012161071A8 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide |
12/12/2013 | US20130331575 Method for resolution of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine |
12/12/2013 | US20130331573 Process for Preparing Piperazine |
12/12/2013 | CA2875165A1 Imino compounds as protecting agents against ultraviolet radiations |
12/11/2013 | EP2671876A2 Pyrazine derivatives and their use as protein kinase inhbitors |
12/11/2013 | EP2670734A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease |
12/11/2013 | CN103435595A Acetylenic heteroaryl compounds |
12/11/2013 | CN103435561A Novel D-amino acid oxidase inhibitor and preparation and application thereof |
12/11/2013 | CN103435560A Synthesis and application of aceanthrylene [1,2-b] quinoxaline derivative with flexible side chain |
12/11/2013 | CN102417509B Application of three compounds extracted from starfish to promotion of bone fracture healing, and preparation method for three compounds |
12/10/2013 | CA2733659C Sulfoxime pesticidal compounds and methods related thereto |
12/05/2013 | WO2013181232A2 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
12/05/2013 | WO2013180149A1 Deuterated nitrogenated heterocyclic carboxamide derivative or salt thereof |
12/05/2013 | US20130324559 Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
12/05/2013 | US20130324519 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors |
12/04/2013 | EP2669265A2 Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate |
12/04/2013 | EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
12/04/2013 | CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications |
12/04/2013 | CN103429577A Method for resolution of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan, 1-yl)-3,3-dimethyl-piperazine |
12/04/2013 | CN103420940A Aralkyl naphthenic aminopiperazine derivatives and applications thereof as multi-targeted antidepressant |
12/04/2013 | CN103420930A Chemical synthetic method of cyadox |
12/04/2013 | CN103420929A Preparation method for tritium or deuterium labeled mequindox |
12/04/2013 | CN103420928A Preparation method of tritium and deuterium labeled quinocetone |
12/04/2013 | CN103420927A Synthetic method of quinoxaline-2-carboxylic acid |
12/04/2013 | CN103420926A Chemical synthetic method of four main metabolites of quinocetone |
12/03/2013 | US8598347 Method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate |
12/03/2013 | US8598173 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors |
12/03/2013 | US8598148 Synthesis of tetracyclines and analogues thereof |
12/03/2013 | CA2658327C Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
11/28/2013 | US20130315825 Tricyclic heteroaromatic compounds as alpha-synuclein ligands |
11/27/2013 | CN103408503A Preparation method of alkaloid compounds, and application of alkaloid compounds in preparing medicines for inhibiting calcium ion channels |
11/26/2013 | US8592584 Compositions and methods including cell death inducers and procaspase activation |
11/26/2013 | US8592415 Selective kinase inhibitors |
11/26/2013 | CA2335240C Cyanine dyes and synthesis methods thereof |
11/21/2013 | WO2013171641A1 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1 |
11/21/2013 | WO2013171535A2 Agent for inhibiting odor of pyrazine derivatives |
11/21/2013 | US20130310320 Boronic ester and acid compounds, synthesis and uses |
11/21/2013 | US20130309272 Compounds for inflammation and immune-related uses |
11/20/2013 | EP2307387B1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
11/20/2013 | EP1757595B1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof |
11/20/2013 | EP1489082B1 Intermediate compounds |
11/20/2013 | CN203295403U Device system used for extracting and refining azophenylene in RT base waste |
11/20/2013 | CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof |
11/20/2013 | CN103396372A 2,5-diketopiperazine derivative, as well as preparation method and application thereof in preparing control agent for resisting marine fouling organisms |
11/20/2013 | CN102245573B Heteroaryl derivatives as cftr modulators |
11/20/2013 | CN102070540B 1-oxygen-2-(1-ethoxy)-3-methyl-quinoxaline, and preparation method and application thereof |
11/20/2013 | CN101506196B Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses |